| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28e3113097dd6d28720572e47f2f2407 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2012-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a409b7ee416b5e00b77821d2d15ecb80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_929dd913d0e925cec2c92e08ce10e2d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6edd60fe739c9fc5adb209696333d4a9 |
| publicationDate |
2013-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201323016-A |
| titleOfInvention |
Oral disintegration ingot |
| abstract |
The present invention relates to a laminated intraoral disintegrating tablet comprising: (1) a layer containing enteric fine particles containing a hydrogen ion pump inhibitor; and (2) a layer containing acetaminosalicylic acid. The orally disintegrating ingot is characterized in that the active ingredient (hydrogen ion-inhibitor, aspirin) has high stability, and the pharmacological effect of the active ingredient after administration is stable and rapid. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113230221-A |
| priorityDate |
2011-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |